Abstract
Aim:The aim of this study was to examine the effects of the use of SSRI by patients in different gynecological operations, through an evaluation of operation type, bleeding amount, requirement for blood and amount of blood transfused. 
 Material and Methods: A retrospective evaluation was made of patients who underwent gynecological surgery. Patients who were taking and not taking SSRI were compared in respect of preoperative and postoperative hemoglobin, hematocrit, platelet count, activated partial thromboplastin time (APTT), INR values, requirement for blood transfusion, and amount of blood transfused. 
 Results: The use of antidepressant drugs by gynaecology patients was not seen to increase bleeding and caused no decrease in hemoglobin or hematocrit values. No statistically significant difference was determined between the groups in respect of the requirement and amount of blood transfusions.
 Conclusion: There is no need to terminate the use of SSRI because of potential bleeding effects or to evaluate patients in respect of these effects. It can be considered sufficient to monitor these patients closely perioperatively and to carefully follow the bleeding protocol.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
